Onderneming Elite Pharmaceuticals, Inc. Other OTC
Aandelen
ELTP
US28659T2006
Farmaceutische producten
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Abbreviated New Drug Applications
100,0
%
| 32 | 100,0 % | 34 | 100,0 % | +5,87% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 32 | 100,0 % | 34 | 100,0 % | +5,87% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Nasrat Hakim
CEO | Chief Executive Officer | 63 | 01-08-13 |
Carter Ward
DFI | Director of Finance/CFO | 59 | 01-07-09 |
Christopher Dick
PSD | President | 69 | 01-11-02 |
Douglas Plassche
COO | Chief Operating Officer | 61 | 12-08-13 |
Dianne Will
IRC | Investor Relations Contact | - | 01-01-03 |
Kirko Kirkov
PRN | Corporate Officer/Principal | 56 | 06-09-22 |
George Smith
LAW | General Counsel | - | 20-10-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jeffrey Whitnell
BRD | Director/Board Member | 68 | 23-10-09 |
Barry Dash
BRD | Director/Board Member | 93 | 01-04-05 |
Davis Caskey
BRD | Director/Board Member | 76 | 28-04-16 |
Nasrat Hakim
CEO | Chief Executive Officer | 63 | 01-08-13 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 017 881 199 | 791 526 006 ( 77,76 %) | 100 000 ( 0,009824 %) | 77,76 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
+20,70% | 43,77 mld. | |
+30,16% | 22,83 mld. | |
+18,68% | 14,34 mld. | |
+54,86% | 12,96 mld. | |
-0,05% | 6,79 mld. | |
-11,72% | 6,41 mld. | |
-8,87% | 5,73 mld. | |
+14,65% | 5,69 mld. | |
+9,49% | 4,75 mld. |